Indacaterol Maleate

马来酸茚达特罗

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameIndacaterol Maleate
Drug Alias NameHirobriz Breezhaler茚达特罗马来酸盐茚达特罗Onbrez BreezhalerOslif Breezhaler +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsHeart FailurePulmonary Disease, Chronic ObstructiveLung Diseases, Obstructive +[5] 
Global Approved IndicationsPulmonary Disease, Chronic Obstructive
Approved Indications in ChinaPulmonary Disease, Chronic Obstructive
Original Approved Country/TerritoryEU
Original Approved Date2009/11/29
Country/TerritoryCzechiaBelgiumCanada +[57] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesHuizheng (Shanghai) Pharmaceutical Technology Co LtdSunovion Pharmaceuticals IncNovartis Pharma Schweiz Ag +[6] 
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsHeart FailureLung Diseases, ObstructiveAsthma +[4] 

Other Information

ATC CodeR03AC18
Related LinksWikipediaDrugBankKEGG